Human Genetics of Prion Diseases

A single change in the prion protein gene can make the difference between developing sporadic Creutzfeldt-Jakob disease and remaining healthy. This research addresses a fundamental gap in knowledge: why some people develop this fatal, untreatable brain disease while others do not. Sporadic CJD appears without warning, and its cause is unknown. By comparing the full genetic makeup of hundreds of patients with that of healthy volunteers, the team aims to identify the specific DNA variants—beyond the known prion protein gene—that increase or decrease a person’s risk. The work is fundamental science. It will not produce a treatment or diagnostic test tomorrow. But identifying risk genes gives researchers concrete molecular targets to investigate. Similar genetic discoveries in other neurodegenerative diseases—such as the *APOE4* gene in Alzheimer’s—have opened entirely new avenues for drug development. If this project succeeds, it will provide the first clear biological leads for understanding what triggers sporadic CJD, and could eventually point toward ways to prevent or slow the disease in people who carry high-risk genetic variants.